MR

Michael Retchin

Founder of NewCo

New York, New York

Overview 

Michael Retchin is a highly accomplished individual with a background in bioinformatics and molecular biology, having held significant roles at prestigious institutions like Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology. Currently, he serves as the Founder of NewCo, leveraging his expertise in entrepreneurship and scientific intelligence to invest in sectors such as Pharmaceuticals and BioTech, particularly focusing on female and diverse founders in regions like New York City and San Francisco Bay Area.

Work Experience 

  • Founder

    2024 - Current

    Building scientific intelligence.

  • Co-President

    2023 - 2024

    Largest global startup accelerator and community for biotech.

  • Founding EVP, Strategy

    2020 - 2023

    Directed global expansion as a member of the founding executive team.

a collaborative venture program enabling the formation of biotechnology companies addressing climate & sustainability challenges

  • Researcher, Chodera Lab

    2020 - 2024

    Worked on reinforcement learning for drug discovery.

  • Senior Associate

    2020 - 2023

    Partnered with founders of life sciences companies.

Pillar VC invests in seed-stage companies, supporting unstoppable founders with capital, connections, coaching, and peer support.

  • Machine Learning

    2020 - 2020

    First ML engineer. Developed new methods for proteomics.

  • Machine Learning

    2017 - 2020

    ProFound Therapeutics (2020) Cellarity (2017-2019)

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Researcher, Shalek Lab

    2019 - 2019

    Developed ML methods for optimizing organoids.

  • Founding Team

    2017 - 2019

    Led ML at therapeutics startup from inception through Series A. Developed the original technology.

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.

Raised $294,000,000.00 from Kyowa Kirin, Flagship Pioneering and Hanwha Impact Partners.

  • Researcher, Sarkar Lab

    2014 - 2015

    My twin brother and I developed an RNA language model based on LSTMs. I validated the model's predictions in the wet lab.

Articles About Michael

Relevant Websites